James Mackaness - Nov 28, 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Chief Financial Officer
Signature
/s/ James Mackaness
Stock symbol
SLNO
Transactions as of
Nov 28, 2023
Transactions value $
-$222,177
Form type
4
Date filed
11/30/2023, 09:52 PM
Previous filing
Dec 13, 2023
Next filing
Dec 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale -$86.6K -3.21K -9.55% $27.03 30.4K Nov 28, 2023 Direct F1, F2
transaction SLNO Common Stock Sale -$18.6K -673 -2.22% $27.59 29.7K Nov 28, 2023 Direct F1, F3
transaction SLNO Common Stock Sale -$59.3K -2.16K -7.28% $27.43 27.5K Nov 29, 2023 Direct F1, F4
transaction SLNO Common Stock Sale -$57.7K -2.04K -7.41% $28.26 25.5K Nov 29, 2023 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $26.465 to $27.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $27.465 to $28.34. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $26.89 to $27.885. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $27.89 to $28.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.